Clinical outcomes of video-assisted thoracic surgery and stereotactic body radiation therapy for early-stage non-small cell lung cancer: A meta-analysis

Thoracic Cancer

Volumn 7, Issue 4, 2016, Pages 442-451

  Ma, Longfei ^a,b   Xiang, Jiaqing ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Lung cancer; SBRT; VATS

Indexed keywords

AGE DISTRIBUTION; ARTICLE; CANCER STAGING; CANCER SURVIVAL; COMPARATIVE EFFECTIVENESS; DISEASE FREE SURVIVAL; EARLY CANCER; FACTUAL DATABASE; HUMAN; META ANALYSIS; NON SMALL CELL LUNG CANCER; OPERABLE PATIENT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT; PRIORITY JOURNAL; STEREOTACTIC BODY RADIATION THERAPY; SURVIVAL RATE; SURVIVAL TIME; VIDEO ASSISTED THORACOSCOPIC SURGERY;

EID: 84990247915     PISSN: 17597706     EISSN: 17597714     Source Type: Journal    
DOI: 10.1111/1759-7714.12352     Document Type: Article

References (54)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. (Published erratum appears in CA Cancer J Clin 2011; 61: 134.) CA Cancer J Clin 2011; 61: 69–90.
2. Zheng R, Zeng H, Zhang S et al. Lung cancer incidence and mortality in China, 2010. Thorac Cancer 2014; 5: 330–6.
3. Chen W, Zheng R, Zhang S, Zou X, Zhao P, He J. Lung cancer incidence and mortality in China, 2009. Thorac Cancer 2013; 4: 102–8.
4. Palma D, Visser O, Lagerwaard FJ, Belderbos J, Slotman BJ, Senan S. Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: A population-based time-trend analysis. J Clin Oncol 2010; 28: 5153–9.
5. Detterbeck FC, Postmus PE, Tanoue LT. The stage classification of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013; 143 (Suppl 5): e191S–210S.
6. McKenna RJ Jr, Houck W, Fuller CB. Video-assisted thoracic surgery lobectomy: Experience with 1,100 cases. Ann Thorac Surg 2006; 81: 421–5.
7. Takagi H, Matsui M, Umemoto T. Long-term survival of VATS versus open lobectomy. Ann Thorac Surg 2011; 92: 408–9.
8. Wright GM, Thursfield VJ, Ball DL et al. Surgical resection and long-term survival outcome for non-small cell lung cancer: A comparison of Victorian population-based studies spanning a decade. Asia-Pac J Clin Oncol 2014; 10: 75–9.
9. Verstegen NE, Oosterhuis JW, Palma DA et al. Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): Outcomes of a propensity score-matched analysis. Ann Oncol 2013; 24: 1543–8.
10. Onishi H, Shirato H, Nagata Y et al. Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: Can SBRT be comparable to surgery? Int J Radiat Oncol Biol Phys 2011; 81: 1352–8.
11. Grills IS, Mangona VS, Welsh R et al. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. J Clin Oncol 2010; 28: 928–35.
12. Norihisa Y, Nagata Y, Takayama K et al. Stereotactic body radiotherapy for oligometastatic lung tumors. Int J Radiat Oncol Biol Phys 2008; 72: 398–403.
13. Rusthoven KE, Kavanagh BD, Burri SH et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol 2009; 27: 1579–84.
14. Grills IS, Hope AJ, Guckenberger M et al. A collaborative analysis of stereotactic lung radiotherapy outcomes for early-stage non-small-cell lung cancer using daily online cone-beam computed tomography image-guided radiotherapy. J Thorac Oncol 2012; 7: 1382–93.
15. Chang BK, Timmerman RD. Stereotactic body radiation therapy: A comprehensive review. Am J Clin Oncol 2007; 30: 637–44.
16. Potters L, Kavanagh B, Galvin JM et al. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 2010; 76: 326–32.
17. Arends LR, Hunink MG, Stijnen T. Meta-analysis of summary survival curve data. Stat Med 2008; 27: 4381–96.
18. Zheng X, Schipper M, Kidwell K et al. Survival outcome after stereotactic body radiation therapy and surgery for stage I non-small cell lung cancer: A meta-analysis. Int J Radiat Oncol Biol Phys 2014; 90: 603–11.
19. Dear KB. Iterative generalized least squares for meta-analysis of survival data at multiple times. Biometrics 1994; 50: 989–1002.
20. Kim K, Kim HK, Park JS et al. Video-assisted thoracic surgery lobectomy: Single institutional experience with 704 cases. Ann Thorac Surg 2010; 89: S2118–22.
21. Puri V, Garg N, Engelhardt EE et al. Tumor location is not an independent prognostic factor in early stage non-small cell lung cancer. Ann Thorac Surg 2010; 89: 1053–9.
22. Sugi K, Kobayashi S, Sudou M, Sakano H, Matsuda E, Okabe K. Long-term prognosis of video-assisted limited surgery for early lung cancer. Eur J Cardiothorac Surg 2010; 37: 456–60.
23. Yamashita S, Chujo M, Kawano Y et al. Clinical impact of segmentectomy compared with lobectomy under complete video-assisted thoracic surgery in the treatment of stage I non-small cell lung cancer. J Surg Res 2011; 166: 46–51.
24. Marty-Ané CH, Canaud L, Solovei L, Alric P, Berthet JP. Video-assisted thoracoscopic lobectomy: An unavoidable trend? A retrospective single-institution series of 410 cases. Interact Cardiovasc Thorac Surg 2013; 17: 36–43.
25. Battoo A, Jahan A, Yang Z et al. Thoracoscopic pneumonectomy: An 11-year experience. Chest 2014; 146: 1300–9.
26. Gonzalez-Rivas D, Fieira E, Delgado M, Mendez L, Fernandez R, de la Torre M. Is uniportal thoracoscopic surgery a feasible approach for advanced stages of non-small cell lung cancer? J Thorac Dis 2014; 6: 641–8.
27. Nakano T, Tetsuka K, Endo T et al. Extraction bag lavage cytology during video-assisted thoracoscopic surgery for primary lung cancer. Interact Cardiovasc Thorac Surg 2014; 18: 770–4.
28. Ghaly G, Kamel M, Nasar A et al. Video-assisted thoracoscopic surgery is a safe and effective alternative to thoracotomy for anatomical segmentectomy in patients with clinical stage I non-small cell lung cancer. Ann Thorac Surg 2015; 101: 465–72.
29. Murakawa T, Ichinose J, Hino H, Kitano K, Konoeda C, Nakajima J. Long-term outcomes of open and video-assisted thoracoscopic lung lobectomy for the treatment of early stage non-small cell lung cancer are similar: A propensity-matched study. World J Surg 2015; 39: 1084–91.
30. Nwogu CE, D'Cunha J, Pang H et al. VATS lobectomy has better perioperative outcomes than open lobectomy: CALGB 31001, an ancillary analysis of CALGB 140202 (Alliance). Ann Thorac Surg 2015; 99: 399–405.
31. Zhou H, Tapias LF, Gaissert HA et al. Lymph node assessment and impact on survival in video-assisted thoracoscopic lobectomy or segmentectomy. Ann Thorac Surg 2015; 100: 910–6.
32. Baba F, Shibamoto Y, Ogino H et al. Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size. Radiat Oncol 2010; 5: 81.
33. Ricardi U, Filippi AR, Guarneri A et al. Stereotactic body radiation therapy for early stage non-small cell lung cancer: Results of a prospective trial. Lung Cancer 2010; 68: 72–7.
34. Timmerman R, Paulus R, Galvin J et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010; 303: 1070–6.
35. Haasbeek CJ, Lagerwaard FJ, Slotman BJ, Senan S. Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer. J Thorac Oncol 2011; 6: 2036–43.
36. Matsuo Y, Shibuya K, Nagata Y et al. Prognostic factors in stereotactic body radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2011; 79: 1104–11.
37. Nath SK, Sandhu AP, Kim D et al. Locoregional and distant failure following image-guided stereotactic body radiation for early-stage primary lung cancer. Radiother Oncol 2011; 99: 12–7.
38. Chang JY, Liu H, Balter P et al. Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer. Radiat Oncol 2012; 7: 152.
39. Nuyttens JJ, van der Voort van Zyp NC, Praag J et al. Outcome of four-dimensional stereotactic radiotherapy for centrally located lung tumors. Radiother Oncol 2012; 102: 383–7.
40. Senthi S, Lagerwaard FJ, Haasbeek CJ, Slotman BJ, Senan S. Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: A retrospective analysis. Lancet Oncol 2012; 13: 802–9.
41. Shibamoto Y, Hashizume C, Baba F et al. Stereotactic body radiotherapy using a radiobiology-based regimen for stage I nonsmall cell lung cancer: A multicenter study. Cancer 2012; 118: 2078–84.
42. Takeda A, Kunieda E, Sanuki N, Aoki Y, Oku Y, Handa H. Stereotactic body radiotherapy (SBRT) for solitary pulmonary nodules clinically diagnosed as lung cancer with no pathological confirmation: Comparison with non-small-cell lung cancer. Lung Cancer 2012; 77: 77–82.
43. Badiyan SN, Bierhals AJ, Olsen JR et al. Stereotactic body radiation therapy for the treatment of early-stage minimally invasive adenocarcinoma or adenocarcnioma in situ (formerly bronchioloalveolar carcinoma): A patterns of failure analysis. Radiat Oncol 2013; 8: 4.
44. Griffioen GH, Lagerwaard FJ, Haasbeek CJ, Smit EF, Slotman BJ, Senan S. Treatment of multiple primary lung cancers using stereotactic radiotherapy, either with or without surgery. Radiother Oncol 2013; 107: 403–8.
45. Yoon SM, Lim YS, Park MJ et al. Stereotactic body radiation therapy as an alternative treatment for small hepatocellular carcinoma. PLoS One 2013; 8 (11): e79854.
46. Haidar YM, Rahn DA III, Nath S et al. Comparison of outcomes following stereotactic body radiotherapy for non-small cell lung cancer in patients with and without pathological confirmation. Ther Adv Respir Dis 2014; 8: 3–12.
47. Lucas JT Jr, Kuremsky JG, Soike M et al. Comparison of accelerated hypofractionation and stereotactic body radiotherapy for stage 1 and node negative stage 2 non-small cell lung cancer (NSCLC). Lung Cancer 2014; 85: 59–65.
48. Ricardi U, Frezza G, Filippi AR et al. Stereotactic ablative radiotherapy for stage I histologically proven non-small cell lung cancer: An Italian multicenter observational study. Lung Cancer 2014; 84: 248–53.
49. ®) patient registry. Radiat Oncol 2015; 10: 113.
50. Davis JN, Medbery C III, Sharma S et al. Stereotactic body radiotherapy for early-stage non-small cell lung cancer: Clinical outcomes from a National Patient Registry. J Radiat Oncol 2015; 4: 55–63.
51. Kelley KD, Benninghoff DL, Stein JS et al. Medically inoperable peripheral lung cancer treated with stereotactic body radiation therapy. Radiat Oncol 2015; 10: 120.
52. Kohutek ZA, Wu AJ, Zhang Z et al. FDG-PET maximum standardized uptake value is prognostic for recurrence and survival after stereotactic body radiotherapy for non-small cell lung cancer. Lung Cancer 2015; 89: 115–20.
53. Zehentmayr F, Wurstbauer K, Deutschmann H et al. DART-bid: Dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily: High local control in early stage (I/II) non-small-cell lung cancer. Strahlenther Onkol. 2015; 191: 256–63.
54. Schanne DH, Nestle U, Allgäuer M et al. Stereotactic body radiotherapy for centrally located stage I NSCLC: A multicenter analysis. Strahlenther Onkol 2015; 191: 125–32.